BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33790491)

  • 61. Treatment of face and scalp solar (actinic) keratosis with daylight-mediated photodynamic therapy is possible throughout the year in Australia: Evidence from a clinical and meteorological study.
    Spelman L; Rubel D; Murrell DF; See JA; Hewitt D; Foley P; Salmon R; Kerob D; Pascual T; Shumack S; Fernandez-Penas P
    Australas J Dermatol; 2016 Feb; 57(1):24-8. PubMed ID: 25827200
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Fractional carbon dioxide laser-assisted photodynamic therapy for patients with actinic keratosis.
    Song HS; Jung SE; Jang YH; Kang HY; Lee ES; Kim YC
    Photodermatol Photoimmunol Photomed; 2015 Nov; 31(6):296-301. PubMed ID: 26012779
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical utility of daylight photodynamic therapy in the treatment of actinic keratosis - a review of the literature.
    Nguyen M; Sandhu SS; Sivamani RK
    Clin Cosmet Investig Dermatol; 2019; 12():427-435. PubMed ID: 31239746
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A review of BF-200 ALA for the photodynamic treatment of mild-to-moderate actinic keratosis.
    Reinhold U
    Future Oncol; 2017 Nov; 13(27):2413-2428. PubMed ID: 28805092
    [TBL] [Abstract][Full Text] [Related]  

  • 65. New aspects in photodynamic therapy of actinic keratoses.
    Smits T; Moor AC
    J Photochem Photobiol B; 2009 Sep; 96(3):159-69. PubMed ID: 19592269
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Randomized Vehicle-Controlled Study of Short Drug Incubation Aminolevulinic Acid Photodynamic Therapy for Actinic Keratoses of the Face or Scalp.
    Pariser DM; Houlihan A; Ferdon MB; Berg JE;
    Dermatol Surg; 2016 Mar; 42(3):296-304. PubMed ID: 26863596
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
    de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Two-Step Irradiance Treatment Can Achieve Excellent Pain Control During Red Light 5-Aminolevulinic Acid Photodynamic Therapy for Actinic Keratoses.
    Paragh G; Zeitouni NC
    Photomed Laser Surg; 2018 Mar; 36(3):174-176. PubMed ID: 29227199
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Tolerability of Photodynamic Therapy Using 10% 5-Aminolevulinic Acid Hydrochloride Gel for Treating Actinic Keratoses on Surface Areas Larger than 75cm
    Moore AY; Moore S
    J Clin Aesthet Dermatol; 2020 Sep; 13(9):45-48. PubMed ID: 33133341
    [No Abstract]   [Full Text] [Related]  

  • 70. A Controlled Comparison Study of Topical Fluourouracil 5% Cream Pre-Treatment of Aminolevulinic Acid/Photodynamic Therapy for Actinic Keratosis.
    Tanghetti EA; Hamann C; Tanghetti M
    J Drugs Dermatol; 2015 Nov; 14(11):1241-4. PubMed ID: 26580872
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Daylight photodynamic therapy versus cryosurgery for the treatment and prophylaxis of actinic keratoses of the face - protocol of a multicenter, prospective, randomized, controlled, two-armed study.
    Kohl E; Koller M; Zeman F; Szeimies RM; Philipp-Dormston WG; Prager W; Gerber PA; Karrer S
    BMC Dermatol; 2017 Oct; 17(1):12. PubMed ID: 29070025
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Daylight-mediated photodynamic therapy for actinic damage in Latin America: consensus recommendations.
    Grinblat B; Galimberti G; Chouela E; Sanclemente G; Lopez M; Alcala D; Torezan L; Pantoja G
    Photodermatol Photoimmunol Photomed; 2016 Mar; 32(2):81-7. PubMed ID: 26541910
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Continuous ultra-low-intensity artificial daylight is not as effective as red LED light in photodynamic therapy of multiple actinic keratoses.
    Wiegell SR; Heydenreich J; Fabricius S; Wulf HC
    Photodermatol Photoimmunol Photomed; 2011 Dec; 27(6):280-5. PubMed ID: 22092730
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Red light photodynamic therapy for actinic keratosis using 37 J/cm
    Vignion-Dewalle AS; Baert G; Devos L; Thecua E; Vicentini C; Mortier L; Mordon S
    Lasers Surg Med; 2017 Sep; 49(7):686-697. PubMed ID: 28370134
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Protoporphyrin IX formation after application of methyl aminolevulinate on the face and scalp with and without prior curettage.
    Heerfordt IM; Bieliauskiene G; Wulf HC
    Photodiagnosis Photodyn Ther; 2018 Jun; 22():155-157. PubMed ID: 29601904
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Aminolaevulinic acid diffusion characteristics in 'in vitro' normal human skin and actinic keratosis: implications for topical photodynamic therapy.
    McLoone N; Donnelly RF; Walsh M; Dolan OM; McLoone S; McKenna K; McCarron PA
    Photodermatol Photoimmunol Photomed; 2008 Aug; 24(4):183-90. PubMed ID: 18717959
    [TBL] [Abstract][Full Text] [Related]  

  • 77. What is the most relevent factor causing pain during ALA-PDT? A multi-center, open clinical pain score research trial of actinic keratosis, acne and condylomata acuminata.
    Zheng Z; Zhang LL; Shi L; Zhang YF; Wang B; Wu QQ; Fang F; Wang WQ; Sroka R; Wang XL
    Photodiagnosis Photodyn Ther; 2019 Jun; 26():73-78. PubMed ID: 30836211
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Daylight photodynamic therapy with MAL cream for large-scale photodamaged skin based on the concept of 'actinic field damage': recommendations of an international expert group.
    Philipp-Dormston WG; Sanclemente G; Torezan L; Tretti Clementoni M; Le Pillouer-Prost A; Cartier H; Szeimies RM; Bjerring P
    J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):8-15. PubMed ID: 26552049
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Temperature-Modulated Photodynamic Therapy for the Treatment of Actinic Keratosis on the Extremities: A One-Year Follow-up Study.
    Willey A; Anderson RR; Sakamoto FH
    Dermatol Surg; 2015 Nov; 41(11):1290-5. PubMed ID: 26445287
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
    Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.